The full House Committee on Oversight and Accountability is scheduled to take up the role of pharmacy benefit managers on Tuesday, May 23, at 10 a.m., after a subcommittee advanced a proposal Wednesday for new transparency rules. The House subcommittee examined the role of PBMs in increasing healthcare costs and in the drug supply chain and determined more transparency is
The drug shortages in the US have reached historic highs. In particular, the scarcity of chemotherapy drugs means people with cancers face delays in treatments which will have lethal consequences.